Pan-Mass Challenge Donates Unprecedented $72 Million to Dana-Farber Cancer InstituteCancer Institute
13 Nov 2023
Record-breaking 2023 Gift Brings the PMC's Total Contributions in Support of Cancer Research and Treatment within Reach of $1 Billion Fundraising Milestone in 2024
BOSTON, Nov. 13, 2023 /PRNewswire/ -- Today, the Pan-Mass Challenge (PMC), the world's single most successful athletic fundraiser, announced its largest gift ever for cancer research, treatment, and care at the world-renowned Dana-Farber Cancer InstituteCancer Institute, a record-breaking $72 million. This impressive gift will bring the PMC's total contributions to $972 million since 1980, positioning the organization to cross a monumental $1 billion in cumulative fundraising for the Institute in 2024.
Continue Reading
Preview
Source: PRNewswire
On Sunday, November 12, 2023, the Pan-Mass Challenge announced a record-breaking $72 million gift to Dana-Farber Cancer InstituteCancer Institute during a celebratory brunch for riders, volunteers, donors, and corporate partners who contributed to this year’s donation. Photo Credit: John Deputy
"Our riders continue to expand the very definition of what a bike-a-thon, and a bicycle, was really meant to do! Their support of the PMC and Dana-Farber is unwavering," said Billy Starr, PMC founder and executive director. "The impact this year's gift has is unparalleled and, as we head towards $1 billion cumulatively raised, this is a proud moment to celebrate the progress that has been made in the fight against cancer thanks in large part to PMC fundraising efforts."
When the PMC began in 1980, the five-year relative survival rate for cancer was 50 percent, and today, it's more than 65 percent. The organization continues to make a profound difference in the lives of patients worldwide, thanks to advances enabled by its robust support of cancer research, treatment, and care at Dana-Farber. In recent years, PMC funding has played a key role in enhancing early detection – for example, Dana-Farber scientists developed new blood tests that precisely detect tumor DNA in Wilms tumor, a rare pediatric kidney cancer, and in recurrent HPV-driven oropharyngeal cancer, a major advancement in finding these cancers early.
This year's $72 million gift was revealed during a celebratory brunch for riders, volunteers, donors, and corporate partners at Legal Harborside in Boston, Massachusetts, on Sunday morning. Notably, and for the 17th consecutive year, the PMC donated 100 percent of every rider-raised dollar to support the lifesaving mission of Dana-Farber. The PMC remains Dana-Farber's largest single contributor, accounting for 62 percent of its Jimmy Fund's annual revenue.
"Year after year, the PMC community's extraordinary support touches every aspect of our organization from our cancer research to the care we deliver to our patients," said Laurie H. Glimcher, MD, president and CEO of Dana-Farber. "As a proud eight-year PMC rider myself, I get to experience the joy of PMC weekend every August and then witness the impact of this extraordinary gift, which is immeasurable to cancer patients both at Dana-Farber and around the world."
In August of this year, 6,500 riders and 3,100 volunteers joined together from across the globe for the 44th PMC, cycling up to 211 miles across the State of Massachusetts to raise this year's record gift. Looking ahead to 2024, the PMC is eager to reconvene its dedicated community of riders, volunteers, donors, and corporate sponsors to not only raise the fundraising bar for cancer research and treatment once again, but to achieve a significant milestone together: $1 billion contributed to fighting cancer.
The PMC is presented by the Red Sox Foundation® and M&T Bank. To learn more or make a financial contribution to the cause, visit www.pmc.org, or call (800) WE-CYCLE. Connect with #PMC2023 on Facebook, X, Instagram and LinkedIn.
About Dana-Farber Cancer InstituteCancer Institute
Dana-Farber Cancer InstituteCancer Institute is one of the world's leading centers of cancer research and treatment. Dana-Farber's mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School. We provide the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 4 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care. As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.
About the Pan-Mass Challenge
The Pan-Mass Challenge (PMC) is a bike-a-thon that today raises more money for charity than any other single athletic fundraising event in the world. The PMC was founded in 1980 by Billy Starr, who remains the event's executive director, an annual cyclist, and a fundraiser. The PMC has since raised $972 million for adult and pediatric patient care and cancer research at Dana-Farber Cancer InstituteCancer Institute through the Jimmy Fund. The event donates 100 percent of every rider-raised dollar directly to the cause, generating 62 percent of the Jimmy Fund's annual revenue as Dana-Farber's single largest contributor. The PMC has successfully melded support from committed cyclists, volunteers, corporate sponsors, and individual contributors, all of which are essential to the PMC's goal and model: to attain maximum fundraising efficiency while increasing its annual gift. The PMC's hope and aspiration is to provide Dana-Farber's doctors and researchers with the necessary resources to discover cures for all cancers. For more information on the Pan-Mass Challenge, visit www.pmc.org.
SOURCE Pan-Mass Challenge
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.